Symmetry Partners LLC Takes $164,000 Position in Senseonics Holdings, Inc. (NYSE:SENS)

Symmetry Partners LLC bought a new position in shares of Senseonics Holdings, Inc. (NYSE:SENS) during the 3rd quarter, HoldingsChannel reports. The institutional investor bought 467,715 shares of the company’s stock, valued at approximately $164,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD increased its holdings in Senseonics by 16.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock worth $196,000 after purchasing an additional 51,000 shares during the period. Cubist Systematic Strategies LLC grew its position in shares of Senseonics by 25.9% during the second quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock worth $166,000 after buying an additional 85,501 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Senseonics by 0.7% during the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock worth $11,963,000 after buying an additional 155,715 shares during the period. State Board of Administration of Florida Retirement System acquired a new stake in Senseonics in the first quarter valued at approximately $91,000. Finally, Mirae Asset Global Investments Co. Ltd. lifted its stake in Senseonics by 30.2% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock worth $483,000 after acquiring an additional 211,128 shares during the last quarter. 12.36% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. HC Wainwright restated a “buy” rating and issued a $2.00 price objective on shares of Senseonics in a report on Wednesday, August 14th. StockNews.com initiated coverage on Senseonics in a research note on Thursday. They issued a “sell” rating on the stock.

Senseonics Price Performance

Shares of Senseonics stock remained flat at $0.34 during trading hours on Friday. 2,347,864 shares of the stock traded hands, compared to its average volume of 3,591,109. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.89 and a current ratio of 3.11. The company’s fifty day moving average price is $0.36 and its 200-day moving average price is $0.40. The firm has a market cap of $181.93 million, a P/E ratio of -2.61 and a beta of 0.79. Senseonics Holdings, Inc. has a fifty-two week low of $0.32 and a fifty-two week high of $0.75.

Senseonics (NYSE:SENS) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.03) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.03). Senseonics had a negative return on equity of 299.69% and a negative net margin of 335.15%. The company had revenue of $4.87 million for the quarter, compared to analyst estimates of $4.86 million. Sell-side analysts expect that Senseonics Holdings, Inc. will post -0.13 EPS for the current year.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.